Tuesday, March 29, 2011

The Future of Drug Discovery

 The new technologies promise to fill drug development pipeline with small molecule candidates is unfulfilled, so pharmaceutical industry is currently undergoing rapid changes, they are moving aggressively into large molecule drug development.
"Drug space” that is not part of the current drug development includes non-Lipinski NCEs, nanomedicines, nucleic acid-based drugs etc will include in future. One of the major challenges for medicinal chemist is to find small molecule inhibitors for protein-protein interactions.